首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.
【24h】

Transplantation of marrow cells from children with standard risk-acute lymphoblastic leukemia at the end of therapy into NOD/SCID mice for detecting residual leukemic cells with in vivo growth potential.

机译:在治疗结束时,将标准风险急性急性淋巴细胞白血病患儿的骨髓细胞移植到NOD / SCID小鼠中,以检测具有体内生长潜力的残留白血病细胞。

获取原文
获取原文并翻译 | 示例
       

摘要

In the present work, we developed a strategy for detecting residual leukemia in the marrow of children with standard risk-acute lymphoblastic leukemia (sr-ALL) at the end of therapy, based on the capacity of human leukemic cells for growing in the NOD/SCID mice marrow microenvironment. Mononuclear (MN) marrow cells from 62 patients were injected into sublethally irradiated NOD/SCID mice and the engraftment kinetics and composition of the human grafts were determined periodically. The presence of human leukemic cells with immunophenotypes and clonal DNA markers similar to those of the original leukemic clone was studied.
机译:在目前的工作中,我们根据人白血病细胞在NOD //下的生长能力,制定了一种在治疗结束时检测标准风险-急性淋巴细胞白血病(sr-ALL)儿童骨髓中残留白血病的策略。 SCID小鼠骨髓微环境。将62例患者的单核(MN)骨髓细胞注射到亚致死剂量辐照下的NOD / SCID小鼠中,并定期测定人移植物的植入动力学和组成。研究了具有与原始白血病克隆相似的免疫表型和克隆DNA标记的人类白血病细胞的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号